Samsung Ventures America, a division of Samsung Venture Investment Corporation headquartered in Seoul, focuses on fostering innovation in the United States and Canada. With a strong presence in major innovation hubs such as the San Francisco Bay Area and Boston, the company is dedicated to supporting emerging technology startups that are poised to shape the future. Its areas of interest include artificial intelligence, robotics, augmented and virtual reality, semiconductors, cybersecurity, 5G, next-generation displays, battery technology, digital health, and insurtech. By backing visionary founders and their groundbreaking ideas, Samsung Ventures America plays a crucial role in the discovery and development of new businesses and technologies in the rapidly evolving tech landscape.
BrickBio, Inc. is a biotechnology company focused on the custom tailoring of proteins through site-specific and site-selective modifications for both research and therapeutic purposes. Founded in 2019 and based in Boston, Massachusetts, BrickBio utilizes a proprietary engineered tRNA synthetase/tRNA pair to enable the selective modification of proteins from eukaryotic and bacterial cell lines. This innovative platform incorporates unnatural amino acids that can be linked to other molecules for various applications, including the development of protein-conjugate therapeutics such as antibody-drug conjugates. By optimizing these modifications, BrickBio aims to enhance the therapeutic efficacy of proteins, facilitating improved treatment options for hospitals and patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.